Patents by Inventor Frank Caiazzo

Frank Caiazzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11529311
    Abstract: A method of regulating pain in a patient includes operations of measuring a patient pain level, determining a dose of ethanol which does not trigger alcohol intolerance or intoxication, delivering the dose of ethanol to the patient by inhalation from an active mesh nebulizer at a repeated interval, measuring the pain level of the patient at a monitoring interval, and determining, based on the patient pain level, whether to adjust the ethanol dose. The dose of ethanol is delivered in the form of particles of nebulized liquid having a diameter ranging from about 0.5 ?m to about 5.0 ?m, which are rapidly absorbed into the bloodstream of a patient and delivered to the brain.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: December 20, 2022
    Assignee: BN INTELLECTUAL PROPERTIES, INC.
    Inventors: Donald M. Pell, Frank Caiazzo
  • Publication number: 20220233436
    Abstract: A method of regulating pain in a patient includes operations of measuring a patient pain level, determining a dose of ethanol which does not trigger alcohol intolerance or intoxication, delivering the dose of ethanol to the patient by inhalation from an active mesh nebulizer at a repeated interval, measuring the pain level of the patient at a monitoring interval, and determining, based on the patient pain level, whether to adjust the ethanol dose. The dose of ethanol is delivered in the form of particles of nebulized liquid having a diameter ranging from about 0.5 ?m to about 5.0 ?m, which are rapidly absorbed into the bloodstream of a patient and delivered to the brain.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 28, 2022
    Inventors: Donald M. PELL, Frank CAIAZZO, Michael P. SPUZA
  • Patent number: 11344686
    Abstract: A method of treating respiratory system tissue, includes operations of generating a plume of particles of a treating solution from a nebulizer, inhaling particles of the treating solution, delaying exhalation of an inhalation having particles of the treating solution therein, and determining whether a dose of the treating solution has been delivered, wherein the treating solution is a solution of at least 40% ethyl alcohol, by volume.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: May 31, 2022
    Assignee: BN INTELLECTUAL PROPERTIES, INC.
    Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza
  • Publication number: 20200353187
    Abstract: A method of treating respiratory system tissue, includes operations of generating a plume of particles of a treating solution from a nebulizer, inhaling particles of the treating solution, delaying exhalation of an inhalation having particles of the treating solution therein, and determining whether a dose of the treating solution has been delivered, wherein the treating solution is a solution of at least 40% ethyl alcohol, by volume.
    Type: Application
    Filed: July 23, 2020
    Publication date: November 12, 2020
    Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza
  • Patent number: 10729648
    Abstract: An active mesh nebulizer is used to generate a distribution of liquid particles or droplets having a diameter ranging from about 0.5 to about 5 micrometers (?m). Delivery and ingestion, by inhalation, of ethyl alcohol solution particles leads to rapid uptake of the alcohol solution by brain tissue, and avoids damage to the liver, gastrointestinal tract, and/or peripheral nervous system consistent with drinking ethyl alcohol. A brain effect of ethyl alcohol absorbed through alveoli in the lung occurs within less than 60 seconds, and body effects of alcohol consumption are reduced or eliminated. Delivery of ethyl alcohol to a user by absorption through alveoli provides a user with a brain effect while allowing tissue damage from drinking alcohol to heal. A lock out barcoded capsule containing ethyl alcohol, tethered to a smartphone application, prevents unauthorized use by non-designated users, or abuse by a designated user.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: August 4, 2020
    Assignee: BN INTELLECTUAL PROPERTIES, INC.
    Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza, Nicholas A. Havercroft
  • Publication number: 20200197299
    Abstract: An active mesh nebulizer is used to generate a distribution of liquid particles or droplets having a diameter ranging from about 0.5 to about 5 micrometers (?m). Delivery and ingestion, by inhalation, of ethyl alcohol solution particles leads to rapid uptake of the alcohol solution by brain tissue, and avoids damage to the liver, gastrointestinal tract, and/or peripheral nervous system consistent with drinking ethyl alcohol. A brain effect of ethyl alcohol absorbed through alveoli in the lung occurs within less than 60 seconds, and body effects of alcohol consumption are reduced or eliminated. Delivery of ethyl alcohol to a user by absorption through alveoli provides a user with a brain effect while allowing tissue damage from drinking alcohol to heal. A lock out barcoded capsule containing ethyl alcohol, tethered to a smartphone application, prevents unauthorized use by non-designated users, or abuse by a designated user.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 25, 2020
    Inventors: Donald M. Pell, Frank Caiazzo, Paula Pell, Govindan P. Nair, Michael P. Spuza, Nicholas A. Havercroft